Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States

Brandi M Limbago; Alexander J Kallen; Wenming Zhu; Paula Eggers; Linda K McDougal; Valerie S Albrecht

doi:10.1128/JCM.02187-13

Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States

J Clin Microbiol. 2014 Mar;52(3):998-1002. doi: 10.1128/JCM.02187-13. Epub 2013 Dec 26.

Authors

Brandi M Limbago¹, Alexander J Kallen, Wenming Zhu, Paula Eggers, Linda K McDougal, Valerie S Albrecht

Affiliation

¹ Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Abstract

Vancomycin-resistant Staphylococcus aureus (VRSA), an important multidrug-resistant organism of public health concern, has been infrequently identified in the United States since 2002. All previous VRSA isolates belonged to clonal complex 5, a lineage associated primarily with health care. This report describes the most recent (13th) U.S. VRSA isolate, the first to be community associated.

Publication types

Case Reports

MeSH terms

Aged
Anti-Bacterial Agents / pharmacology
Cluster Analysis
Community-Acquired Infections / microbiology
Electrophoresis, Gel, Pulsed-Field
Genotype
Humans
Male
Microbial Sensitivity Tests
Molecular Typing
Staphylococcal Infections / microbiology*
Staphylococcus aureus / classification
Staphylococcus aureus / drug effects*
Staphylococcus aureus / genetics
Staphylococcus aureus / isolation & purification*
United States
Vancomycin Resistance*

Substances

Anti-Bacterial Agents